We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$33.8B
AUM Growth
+$4.19B
Cap. Flow
+$264M
Cap. Flow %
0.78%
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$52.4M
2
TSLA icon
Tesla
TSLA
+$42.1M
3
MSFT icon
Microsoft
MSFT
+$16.9M
4
DIS icon
Walt Disney
DIS
+$14.5M
5
MS icon
Morgan Stanley
MS
+$11.9M

Top Sells

Rank Stock Value
1
UN
Unilever NV New York Registry Shares
UN
+$48.8M
2
T icon
AT&T
T
+$25.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$20M
4
AMZN icon
Amazon
AMZN
+$15.7M
5
BIIB icon
Biogen
BIIB
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Financials 13.6%
3 Healthcare 13.1%
4 Consumer Discretionary 11.54%
5 Communication Services 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
26
Comcast
CMCSA
$85.1B
$192M 0.57%
3,669,326
-9,553
-0.3% -$458K
INTC icon
27
Intel
INTC
$494B
$188M 0.56%
3,782,039
-217,535
-5% -$10.6M
MRK icon
28
Merck
MRK
$309B
$187M 0.55%
2,393,982
-58,780
-2% -$4.5M
PEP icon
29
PepsiCo
PEP
$183B
$183M 0.54%
1,237,308
+7,824
+0.6% +$1.11M
NKE icon
30
Nike
NKE
$63.9B
$179M 0.53%
1,263,427
+33,362
+3% +$4.42M
NFLX icon
31
Netflix
NFLX
$285B
$170M 0.5%
3,143,160
+29,560
+0.9% +$1.5M
TXN icon
32
Texas Instruments
TXN
$261B
$168M 0.5%
1,026,167
-6,284
-0.6% -$977K
ABT icon
33
Abbott
ABT
$178B
$168M 0.5%
1,534,563
+27,477
+2% +$2.99M
BAC icon
34
Bank of America
BAC
$425B
$163M 0.48%
5,371,065
+130,540
+2% +$3.5M
COST icon
35
Costco
COST
$416B
$159M 0.47%
422,391
-6,123
-1% -$2.29M
DHR icon
36
Danaher
DHR
$144B
$159M 0.47%
807,727
+429
+0.1% +$86K
CSCO icon
37
Cisco
CSCO
$439B
$159M 0.47%
3,552,224
-150,642
-4% -$6.19M
ABBV icon
38
AbbVie
ABBV
$447B
$151M 0.45%
1,407,649
+28,003
+2% +$2.69M
BABA icon
39
Alibaba
BABA
$291B
$147M 0.43%
630,929
+659
+0.1% +$183K
PFE icon
40
Pfizer
PFE
$142B
$144M 0.43%
3,916,862
-234,213
-6% -$8.59M
MCD icon
41
McDonald's
MCD
$189B
$138M 0.41%
643,322
+20,309
+3% +$4.42M
CRM icon
42
Salesforce
CRM
$142B
$132M 0.39%
593,314
+10,974
+2% +$2.67M
HON icon
43
Honeywell
HON
$71.9B
$131M 0.39%
651,218
-6,279
-1% -$1.14M
ORCL icon
44
Oracle
ORCL
$353B
$126M 0.37%
1,950,927
+38,246
+2% +$2.28M
LLY icon
45
Eli Lilly
LLY
$1.03T
$126M 0.37%
746,049
-34,415
-4% -$5.14M
AMGN icon
46
Amgen
AMGN
$197B
$126M 0.37%
547,545
-34,233
-6% -$7.89M
TGT icon
47
Target
TGT
$63.4B
$125M 0.37%
708,087
-1,479
-0.2% -$247K
QCOM icon
48
Qualcomm
QCOM
$181B
$125M 0.37%
820,439
+42,345
+5% +$5.9M
KO icon
49
Coca-Cola
KO
$350B
$122M 0.36%
2,219,692
-54,692
-2% -$2.83M
UNP icon
50
Union Pacific
UNP
$177B
$119M 0.35%
571,910
+10,980
+2% +$2.19M

Similar funds

Aperio Group's Q4 2020 Portfolio in Review

As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
  • Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
  • Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
  • Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
  • Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
  • Aperio Group opened 104 new positions and closed 53 in Q4 2020.
  • Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.